Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells.

Setegne, Mekedlawit T et al.·ACS bio & med chem Au·2025·Preliminary Evidencelaboratory study
RPEP-13513Laboratory studyPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
laboratory study
Evidence
Preliminary Evidence
Sample
N=Not applicable (cell culture study)
Participants
HUDEP-2 erythroid progenitor cells and primary CD34+ hematopoietic stem cells

What This Study Found

Different protein delivery vehicles (cell-penetrating peptides, bacterial toxins, injection systems) showed widely varying ability to deliver cargo into erythroid precursor cells. Targeting cell surface receptors improved some vehicles but not others.

Key Numbers

Multiple CPPs, CPP additives, bacterial toxins, and contractile injection systems evaluated. Delivery to HUDEP-2 and CD34+ cells. Some vehicles benefited from receptor targeting; others did not.

How They Did This

Evaluated cell-penetrating peptides, CPP additives, bacterial toxins, and contractile injection systems for cargo delivery to HUDEP-2 erythroid progenitor cells and primary CD34+ hematopoietic stem cells. Tested receptor-mediated targeting strategies.

Why This Research Matters

Red blood cell precursors are notoriously hard to deliver drugs into. This systematic comparison identifies the best strategies for this challenging cell type, important for treating blood diseases like sickle cell and thalassemia.

What This Study Doesn't Tell Us

In vitro study. Cell line results may not reflect primary cell behavior in vivo. No animal testing. Delivery efficiency for therapeutic payloads not directly measured for all vehicles.

Trust & Context

Original Title:
Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells.
Published In:
ACS bio & med chem Au, 5(2), 268-282 (2025)
Database ID:
RPEP-13513

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-13513·https://rethinkpeptides.com/research/RPEP-13513

APA

Setegne, Mekedlawit T; Cabral, Aidan T; Tiwari, Anushri; Shen, Fangfang; Thiam, Hawa Racine; Dassama, Laura M K. (2025). Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells.. ACS bio & med chem Au, 5(2), 268-282. https://doi.org/10.1021/acsbiomedchemau.4c00098

MLA

Setegne, Mekedlawit T, et al. "Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells.." ACS bio & med chem Au, 2025. https://doi.org/10.1021/acsbiomedchemau.4c00098

RethinkPeptides

RethinkPeptides Research Database. "Engineering Cell-Specific Protein Delivery Vehicles for Eryt..." RPEP-13513. Retrieved from https://rethinkpeptides.com/research/setegne-2025-engineering-cellspecific-protein-delivery

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.